PSMA expression in melanoma (V2)

• Research type

  Research Study

• Full title

  Prostate-specific membrane antigen (PSMA) expression in metastatic melanoma

• IRAS ID

  241550

• Contact name

  Hayden Snow

• Contact email

  hayden.snow@rmh.nhs.uk

• Sponsor organisation

  The Royal Marsden NHS Foundation Trust

• Duration of Study in the UK

  0 years, 4 months, 30 days

• Research summary

  This study is aiming to establish whether a protein called PSMA can help diagnose melanoma deposits in the body. Detection of PSMA is widely used in the diagnosis of prostate cancer. PSMA has recently been detected in melanoma, so we will examine the accuracy of the detection of PSMA in the diagnosis of melanoma

• REC name

  Yorkshire & The Humber - Leeds West Research Ethics Committee

• REC reference

  18/YH/0259

• Date of REC Opinion

  4 Jul 2018

• REC opinion

  Favourable Opinion